Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (841-850 of 910) with videos related to

Pageof 91
Sort By:
Human Gene Therapy|August 19, 2023
Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase DeficiencyNeel Mehta, Rénald Gilbert, Parminder S Chahal, et al.
The EMBO Journal|July 4, 2003
Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor traffickingMartina Metzler, Bo Li, Lu Gan, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 21, 2018
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general populationChris Kay, Jennifer A Collins, Galen E B Wright, et al.
Human Molecular Genetics|July 22, 2011
Altered palmitoylation and neuropathological deficits in mice lacking HIP14Roshni R Singaraja, Kun Huang, Shaun S Sanders, et al.
Human Gene Therapy|November 2, 2005
Gene therapy for lipoprotein lipase deficiency: working toward clinical applicationJaap Rip, Melchior C Nierman, Jeroen A Sierts, et al.
Diabetes|October 15, 2011
Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granulesJanine K Kruit, Nadeeja Wijesekara, Jocelyn E Manning Fox, et al.
Neuropsychologia|February 17, 2007
Verbal episodic memory declines prior to diagnosis in Huntington's diseaseAndrea C Solomon, Julie C Stout, Shannon A Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2019
Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington diseaseCostanza Ferrari Bardile, Marta Garcia-Miralles, Nicholas S Caron, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nucleaseKatherine Tan, Daniela Del Bosque Siller, Alisha Y Xiong, et al.
Pageof 91

Showing results (841-850 of 910) with videos related to

Sort By:
Pageof 91
Human Gene Therapy|August 19, 2023
Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase DeficiencyNeel Mehta, Rénald Gilbert, Parminder S Chahal, et al.
The EMBO Journal|July 4, 2003
Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor traffickingMartina Metzler, Bo Li, Lu Gan, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 21, 2018
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general populationChris Kay, Jennifer A Collins, Galen E B Wright, et al.
Human Molecular Genetics|July 22, 2011
Altered palmitoylation and neuropathological deficits in mice lacking HIP14Roshni R Singaraja, Kun Huang, Shaun S Sanders, et al.
Human Gene Therapy|November 2, 2005
Gene therapy for lipoprotein lipase deficiency: working toward clinical applicationJaap Rip, Melchior C Nierman, Jeroen A Sierts, et al.
Diabetes|October 15, 2011
Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granulesJanine K Kruit, Nadeeja Wijesekara, Jocelyn E Manning Fox, et al.
Neuropsychologia|February 17, 2007
Verbal episodic memory declines prior to diagnosis in Huntington's diseaseAndrea C Solomon, Julie C Stout, Shannon A Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2019
Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington diseaseCostanza Ferrari Bardile, Marta Garcia-Miralles, Nicholas S Caron, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nucleaseKatherine Tan, Daniela Del Bosque Siller, Alisha Y Xiong, et al.
Pageof 91